213 related articles for article (PubMed ID: 33523367)
1. CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors.
Benedetti G; Mori M; Panzeri MM; Barbera M; Palumbo D; Sini C; Muffatti F; Andreasi V; Steidler S; Doglioni C; Partelli S; Manzoni M; Falconi M; Fiorino C; De Cobelli F
Radiol Med; 2021 Jun; 126(6):745-760. PubMed ID: 33523367
[TBL] [Abstract][Full Text] [Related]
2. Robustness of CT radiomic features against image discretization and interpolation in characterizing pancreatic neuroendocrine neoplasms.
Loi S; Mori M; Benedetti G; Partelli S; Broggi S; Cattaneo GM; Palumbo D; Muffatti F; Falconi M; De Cobelli F; Fiorino C
Phys Med; 2020 Aug; 76():125-133. PubMed ID: 32673824
[TBL] [Abstract][Full Text] [Related]
3. Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features.
Mori M; Palumbo D; Muffatti F; Partelli S; Mushtaq J; Andreasi V; Prato F; Ubeira MG; Palazzo G; Falconi M; Fiorino C; De Cobelli F
Eur Radiol; 2023 Jun; 33(6):4412-4421. PubMed ID: 36547673
[TBL] [Abstract][Full Text] [Related]
4. Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer.
Cong M; Feng H; Ren JL; Xu Q; Cong L; Hou Z; Wang YY; Shi G
Lung Cancer; 2020 Jan; 139():73-79. PubMed ID: 31743889
[TBL] [Abstract][Full Text] [Related]
5. Can peritumoral radiomics increase the efficiency of the prediction for lymph node metastasis in clinical stage T1 lung adenocarcinoma on CT?
Wang X; Zhao X; Li Q; Xia W; Peng Z; Zhang R; Li Q; Jian J; Wang W; Tang Y; Liu S; Gao X
Eur Radiol; 2019 Nov; 29(11):6049-6058. PubMed ID: 30887209
[TBL] [Abstract][Full Text] [Related]
6. Prediction of pathological nodal involvement by CT-based Radiomic features of the primary tumor in patients with clinically node-negative peripheral lung adenocarcinomas.
Liu Y; Kim J; Balagurunathan Y; Hawkins S; Stringfield O; Schabath MB; Li Q; Qu F; Liu S; Garcia AL; Ye Z; Gillies RJ
Med Phys; 2018 Jun; 45(6):2518-2526. PubMed ID: 29624702
[TBL] [Abstract][Full Text] [Related]
7. Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a radiomic model to predict tumor grade.
Chiti G; Grazzini G; Flammia F; Matteuzzi B; Tortoli P; Bettarini S; Pasqualini E; Granata V; Busoni S; Messserini L; Pradella S; Massi D; Miele V
Radiol Med; 2022 Sep; 127(9):928-938. PubMed ID: 35917099
[TBL] [Abstract][Full Text] [Related]
8. The MR radiomic signature can predict preoperative lymph node metastasis in patients with esophageal cancer.
Qu J; Shen C; Qin J; Wang Z; Liu Z; Guo J; Zhang H; Gao P; Bei T; Wang Y; Liu H; Kamel IR; Tian J; Li H
Eur Radiol; 2019 Feb; 29(2):906-914. PubMed ID: 30039220
[TBL] [Abstract][Full Text] [Related]
9. Radiomic-Based Pathological Response Prediction from Primary Tumors and Lymph Nodes in NSCLC.
Coroller TP; Agrawal V; Huynh E; Narayan V; Lee SW; Mak RH; Aerts HJWL
J Thorac Oncol; 2017 Mar; 12(3):467-476. PubMed ID: 27903462
[TBL] [Abstract][Full Text] [Related]
10. CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study.
Gu D; Hu Y; Ding H; Wei J; Chen K; Liu H; Zeng M; Tian J
Eur Radiol; 2019 Dec; 29(12):6880-6890. PubMed ID: 31227882
[TBL] [Abstract][Full Text] [Related]
11. Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients.
Crivellaro C; Landoni C; Elisei F; Buda A; Bonacina M; Grassi T; Monaco L; Giuliani D; Gotuzzo I; Magni S; Di Martino G; Delle Marchette M; Guerra L; Landoni F; Fruscio R; Messa C; De Bernardi E
Int J Gynecol Cancer; 2020 Mar; 30(3):378-382. PubMed ID: 32079712
[TBL] [Abstract][Full Text] [Related]
12. Value of [
Li K; Sun H; Lu Z; Xin J; Zhang L; Guo Y; Guo Q
Eur J Radiol; 2018 Sep; 106():160-166. PubMed ID: 30150039
[TBL] [Abstract][Full Text] [Related]
13. Accurate non-invasive grading of nonfunctional pancreatic neuroendocrine tumors with a CT derived radiomics signature.
Javed AA; Zhu Z; Kinny-Köster B; Habib JR; Kawamoto S; Hruban RH; Fishman EK; Wolfgang CL; He J; Chu LC
Diagn Interv Imaging; 2024 Jan; 105(1):33-39. PubMed ID: 37598013
[TBL] [Abstract][Full Text] [Related]
14. Prediction of the World Health Organization Grade of rectal neuroendocrine tumors based on CT histogram analysis.
Liang P; Xu C; Tan F; Li S; Chen M; Hu D; Kamel I; Duan Y; Li Z
Cancer Med; 2021 Jan; 10(2):595-604. PubMed ID: 33263225
[TBL] [Abstract][Full Text] [Related]
15. Radiomic feature reproducibility in contrast-enhanced CT of the pancreas is affected by variabilities in scan parameters and manual segmentation.
Yamashita R; Perrin T; Chakraborty J; Chou JF; Horvat N; Koszalka MA; Midya A; Gonen M; Allen P; Jarnagin WR; Simpson AL; Do RKG
Eur Radiol; 2020 Jan; 30(1):195-205. PubMed ID: 31392481
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of texture analysis for grading pancreatic neuroendocrine tumors on contrast-enhanced computed tomography and apparent diffusion coefficient maps.
Ohki K; Igarashi T; Ashida H; Takenaga S; Shiraishi M; Nozawa Y; Ojiri H
Jpn J Radiol; 2021 Jan; 39(1):66-75. PubMed ID: 32885378
[TBL] [Abstract][Full Text] [Related]
17. Machine-learning-based computed tomography radiomic analysis for histologic subtype classification of thymic epithelial tumours.
Hu J; Zhao Y; Li M; Liu Y; Wang F; Weng Q; You R; Cao D
Eur J Radiol; 2020 May; 126():108929. PubMed ID: 32169748
[TBL] [Abstract][Full Text] [Related]
18. Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy.
Polk SL; Choi JW; McGettigan MJ; Rose T; Ahmed A; Kim J; Jiang K; Balagurunathan Y; Qi J; Farah PT; Rathi A; Permuth JB; Jeong D
World J Gastroenterol; 2020 Jun; 26(24):3458-3471. PubMed ID: 32655269
[TBL] [Abstract][Full Text] [Related]
19. Cross-modality PET/CT and contrast-enhanced CT imaging for pancreatic cancer.
Zhang J; Zuo CJ; Jia NY; Wang JH; Hu SP; Yu ZF; Zheng Y; Zhang AY; Feng XY
World J Gastroenterol; 2015 Mar; 21(10):2988-96. PubMed ID: 25780297
[TBL] [Abstract][Full Text] [Related]
20. Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT.
Kawanaka Y; Kitajima K; Fukushima K; Mouri M; Doi H; Oshima T; Niwa H; Kaibe N; Sasako M; Tomita T; Miwa H; Hirota S
Eur J Radiol; 2016 May; 85(5):989-95. PubMed ID: 27130061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
